Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ORTHOPEDIATRICS CORP.

(KIDS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OrthoPediatrics : Needham Adjusts OrthoPediatrics' Price Target to $83 From $77, Maintains Buy Rating

08/06/2021 | 06:05am EST


ę MT Newswires 2021
All news about ORTHOPEDIATRICS CORP.
01/13BONESUPPORT signs distribution agreement with OrthoPediatrics
AQ
01/10ORTHOPEDIATRICS : Announces Preliminary Unaudited Revenue for the Fourth Quarter & Full-Ye..
PU
01/10ORTHOPEDIATRICS CORP : Results of Operations and Financial Condition, Regulation FD Disclo..
AQ
01/10OrthoPediatrics Expects 31% Increase in Q4 Revenue
MT
01/10OrthoPediatrics Announces Preliminary Unaudited Revenue for the Fourth Quarter & Full-Y..
AQ
01/10OrthoPediatrics Corp. Provides Preliminary Unaudited Revenue Guidance for the Fourth Qu..
CI
01/06ORTHOPEDIATRICS CORP : Entry into a Material Definitive Agreement, Creation of a Direct Fi..
AQ
01/06OrthoPediatrics Corp. and Squadron Capital LLC enter Third Amendment to its Fourth Amen..
CI
2021BTIG Adjusts OrthoPediatrics' Price Target to $68 From $75, Keeps Buy Rating
MT
2021Truist Securities Adjusts OrthoPediatrics' Price Target to $75 From $78, Maintains Buy ..
MT
More news
Analyst Recommendations on ORTHOPEDIATRICS CORP.
More recommendations
Financials (USD)
Sales 2021 98,0 M - -
Net income 2021 -23,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -39,6x
Yield 2021 -
Capitalization 936 M 936 M -
Capi. / Sales 2021 9,55x
Capi. / Sales 2022 7,84x
Nbr of Employees 116
Free-Float 69,9%
Chart ORTHOPEDIATRICS CORP.
Duration : Period :
OrthoPediatrics Corp. Technical Analysis Chart | KIDS | US68752L1008 | MarketScreener
Technical analysis trends ORTHOPEDIATRICS CORP.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 47,54 $
Average target price 77,17 $
Spread / Average Target 62,3%
EPS Revisions
Managers and Directors
David R. Bailey President, Chief Executive Officer & Director
Fred L. Hite Director, Chief Operating & Financial Officer
Mark C. Throdahl Executive Chairman
Peter F. Armstrong Chief Medical Officer
Joel Batts Senior Vice President-Science & Technology
Sector and Competitors